"Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined." ...
The U.S. Centers for Medicare and Medicaid Services has revised its policy permitting multiple uses of amyloid positron emission tomography (PET) scans, a non-invasive brain scan crucial for ...
WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, who suffers from Alzheimer's, prepares to receive a PET scan at MedStar Georgetown University Hospital in Washington, DC. (Photo by Michael Robinson Chávez ...
Amyloid PET scans provide in-vivo evidence of Alzheimer's disease (AD) pathology. However, due to their high cost and limited insurance coverage, they are not widely used in clinical settings outside ...
A Centers for Medicare and Medicaid decision memorandum issued last month lifts restrictions on coverage of Alzheimer’s disease diagnostics that measure beta amyloid plaque in the brain. Excessive ...
A new study finds that using amyloid positron emission tomography scans can slightly reduce hospitalizations in people with mild cognitive impairment or dementia. “In the context of the increased ...
The Centers for Medicare & Medicaid Services (CMS) has expanded coverage of brain amyloid positron-emission tomography (PET) imaging for the diagnosis of Alzheimer's disease (AD). The CMS decision, ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed more than 10,000 PET scans of patients from the IDEAS study. Measurement of Centiloids from ...
In amyloid PET, visual and quantitative reads are at odds 6 percent of the time. In some instances, regional accumulation might be to blame. People with discordant scans accumulated amyloid faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results